未登录Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)
Tang, Haowen; Zhang, Wenwen; Cao, Junning; Cao, Yinbiao; Bi, Xinyu; Zhao, Haitao; Zhang, Ze; Liu, Zhe; Wan, Tao; Lang, Ren; Sun, Wenbing; Du, Shunda; Yang, Yongping; Lu, Yinying; Zeng, Daobing; Wu, Jushan; Duan, Binwei; Lin, Dongdong; Li, Fei; Meng, Qinghua; Zhou, Jun; Xing, Baocai; Tian, Xiaodong; Zhu, Jiye; Gao, Jie; Hao, Chunyi; Wang, Zhiqiang; Duan, Feng; Wang, Zhijun; Wang, Maoqiang; Liang, Bin; Chen, Yongwei; Xu, Yinzhe; Li, Kai; Li, Chengang; Hu, Minggen; Wang, Zhaohai; Cai, Shouwang; Ji, Wenbin; Xia, Nianxin; Zheng, Wenheng; Wang, Hongguang; Li, Gong; Zhu, Ziman; Huang, Zhiyong; Zhang, Wanguang; Tao, Kaishan; Liang, Jun; Zhang, Keming; Dai, Chaoliu; Li, Jiangtao; Qiu, Qiu; Guo, Yuan; Wu, Liqun; Ding, Weibao; Zhu, Zhenyu; Gu, Wanqing; Cao, Jingyu; Wang, Zusen; Tian, Lantian; Ding, Huiguo; Li, Guangming; Zeng, Yongyi; Wang, Kui; Yang, Ning; Jin, Haosheng; Chen, Yajin; Yang, Yinmo; Xiu, Dianrong; Yan, Maolin; Wang, Xiaodong; Han, Quanli; Jiao, Shunchang; Tan, Guang; Wang, Jizhou; Liu, Lianxin; Song, Jinghai; Liao, Jiajie; Zhao, Hong; Li, Peng; Song, Tianqiang; Wang, Zhanbo; Yuan, Jing; Hu, Bingyang; Yuan, Yufeng; Zhang, Meng; Sun, Shuyang; Zhang, Jialin; Wang, Wentao; Wen, Tianfu; Yang, Jiayin; Du, Xilin; Peng, Tao; Xia, Feng; Liu, Zuojin; Niu, Weibo; Liang, Ping; Xu, Jianming; Zhao, Xiao; Zhu, Min; Wang, Huaizhi; Kuang, Ming; Shen, Shunli; Cui, Xing; Zhou, Jinxue; Liu, Rong; Sun, Huichuan; Fan, Jia; Chen, Xiaoping; Zhou, Jian; Cai, Jianqiang; Lu, Shichun .png)
分享.png)
收藏分享 收藏 Primary results from the phase III ALTN-AK105-III-02 study: Anlotinib plus penpulimab versus sorafenib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)III期ALTN-AK105-III-02研究的主要结果：安罗替尼联合penpulimab与索拉非尼作为晚期肝细胞癌（aHCC）的一线（1L）治疗比较。Zhou, J.; Fan, J.; Jiao, S. C.; Bai, L.; Luo, J.; Bai, Y.; Pan, Y.; Gao, Y.; Shi, R.; Zhang, W.; Zheng, J.; Hua, X.; Aibing, X.; Hu, S.; Da, M.; Wang, R.; Ma, J.; Jia, W.; Wu, W.; Peng, C. 分享 收藏 分享 收藏 First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trialZhong, Hua; Sun, Shengjie; Chen, Jianhua; Wang, Ziping; Zhao, Yanqiu; Zhang, Guojun; Chen, Gongyan; Zhou, Ming; Zhou, Jianying; Du, Yingying; Wu, Lin; Xu, Zhi; Mei, Xiaodong; Zhang, Weidong; He, Jingdong; Cui, Jiuwei; Zhang, Zhihong; Luo, Hui; Liu, Weiyou; Sun, Meili; Wu, Jingxun; Shen, Yongchun; Zhang, Shucai; Yang, Nong; Wang, Mengzhao; Lu, Junguo; Li, Kai; Yao, Weirong; Sun, Qian; Yue, Hongmei; Wang, Lin; Ye, Sheng; Li, Bin; Zhuang, Xibin; Pan, Yueyin; Zhang, Min; Shu, Yongqian; He, Zhiyong; Pan, Lei; Ling, Yang; Liu, Shengming; Zhang, Qi; Jiao, Shunchang; Han, Baohui 分享 收藏 Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionHu, Guan-hua; Cheng, Yi-fei; Zuo, Ying-xi; Chang, Ying-jun; Suo, Pan; Wu, Jun; Jia, Yue-ping; Lu, Ai-dong; Li, Ying-chun; Wang, Yu; Jiao, Shun-chang; Zhang, Long-ji; Zhao, Xiang-yu; Yan, Chen-hua; Xu, Lan-ping; Zhang, Xiao-hui; Liu, Kai-yan; Zhang, Le-ping; Huang, Xiao-jun 分享 收藏 Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)Han, Chun; Ye, Sisi; Hu, Chunhong; Shen, Liangfang; Qin, Qun; Bai, Yuxian; Yang, Shizhong; Bai, Chunmei; Zang, Aimin; Jiao, Shunchang; Bai, Li 分享 收藏 Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyHu, Guan-Hua; Zhao, Xiang-Yu; Zuo, Ying-Xi; Chang, Ying-Jun; Suo, Pan; Wu, Jun; Jia, Yue-Ping; Lu, Ai-Dong; Li, Ying-Chun; Wang, Yu; Jiao, Shun-Chang; Zhang, Long-Ji; Kong, Jun; Yan, Chen-Hua; Xu, Lan-Ping; Zhang, Xiao-Hui; Liu, Kai-Yan; Cheng, Yi-Fei; Wang, Yu; Zhang, Le-Ping; Huang, Xiao-Jun 分享 收藏 分享 收藏 Integrated safety analysis of anti-programmed cell death-1 (PD-1) antibody penpulimab in advanced solid tumour or lymphomaXu, N.; Han, B.; Jiao, S.; Hu, C.; Mislang, A.; Coward, J.; Cooper, A.; Underhill, C.; Xia, Y.; Xia, D.; Jin, X.; Wang, Z. M.; Li, B. 分享 收藏 分享 收藏 分享 收藏 Sequential treatment with aT19 cells generates memory CAR-T cells and prolongs the lifespan of Raji-B-NDG miceChen, Ruifeng; Wang, Meng; Liu, Qiang; Wu, Jiajing; Huang, Weijing; Li, Xuejiao; Du, Baohua; Xu, Qilong; Duan, Jingjing; Jiao, Shunchang; Lee, Hyun Soo; Jung, Nam-Chul; Lee, Jun-Ho; Wang, Yu; Wang, Youchun 分享 收藏 分享 收藏 分享 收藏 FcR deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathwayWei, Zhi-Min; Wang, Zhuo; Wan, Xiao-Jian; Li, Xian-Jing; Li, Yi-Xing; Bai, Yang; Yang, Xue; Yang, Yong; Jiao, Shun-Chang; Liu, Zhe-Feng 分享 收藏 分享 收藏 A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityXu, Xiaojie; Fan, Zhongyi; Liang, Chaoyang; Li, Ling; Wang, Lili; Liang, Yingchun; Wu, Jun; Chang, Shaohong; Yan, Zhifeng; Lv, Zhaohui; Fu, Jing; Liu, Yang; Jin, Shuai; Wang, Tao; Hong, Tian; Dong, Yishan; Ding, Lihua; Cheng, Long; Liu, Rui; Fu, Shenbo; Jiao, Shunchang; Ye, Qinong 分享 收藏 MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expressionFan, Z.; Cui, H.; Yu, H.; Ji, Q.; Kang, L.; Han, B.; Wang, J.; Dong, Q.; Li, Y.; Yan, Z.; Yan, X.; Zhang, X.; Lin, Z.; Hu, Y.; Jiao, S. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
